• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

C Infect Dis . The host immune response of a discharged COVID-19 patient with twice reemergence of SARS-CoV-2: a case report

tetano

Editor, Senior Moderator
C Infect Dis


. 2021 Sep 23;21(1):991.
doi: 10.1186/s12879-021-06679-3.
The host immune response of a discharged COVID-19 patient with twice reemergence of SARS-CoV-2: a case report


Xiaobin Zao[SUP] #[/SUP][SUP] 1 2 [/SUP], Yang Zhou[SUP] #[/SUP][SUP] 3 [/SUP], Yijun Liang[SUP] 1 4 [/SUP], Xu Cao[SUP] 1 4 [/SUP], Hening Chen[SUP] 1 4 [/SUP], Xiaoke Li[SUP] 5 6 [/SUP], Yong'an Ye[SUP] 7 8 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. There have been reports that long-term SARS-CoV-2 RNA shedding and re-infection of COVID-19 patients existed. However, the specific mechanism, diagnosis, and treatment of COVID-19 are still unclarified.
Case presentation: In this case, we reported a 64-year-old patient who had a long-term course of COVID-19 for 174 days with two retests of SARS-CoV-2 RNA positive after discharging from the hospital. The patient's serum immunoglobulin G (IgG) of SARS-CoV-2 tested positive after the initial infection. And during treatment, the CD4 + T cell count and ratio to peripheral blood mononuclear cell (PBMC) were in dynamic change.
Conclusions: Our results suggested that the host immune system responded with IgG production after SARS-CoV-2 infection, but was not protective enough for the patient. The reemergence of SARS-CoV-2 could be related to the cell count and proportion of CD4 + T cells in PBMC. And the increase of CD4 + T cells after treatment may help to clear the virus.

Keywords: COVID-19; Host immune response; RNA test; Reemergence; SARS-CoV-2.
 
Back
Top Bottom